1-3 of 3
Marius Giurescu
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Results of the Mantle Cell Lymphoma Subset from a Phase 2a Study of Copanlisib, a Novel PI3K Inhibitor, in Patients with Indolent and Aggressive Lymphoma

Free
David Cunningham, Pier Luigi Zinzani, MD PhD, Sarit E. Assouline, MDMSc, Krimo Bouabdallah, MD, Dominique Bron, MD PhD, Corinne Haioun, MD PhD, Luigina Mollica, MD FRCPC, PhD, Marius Giurescu, MDPhD, Igor Gorbatchevsky, MD, Manoel Neves, MD, Marta M. Lemos, MD, Julia Grunert, PhD, Florian Hiemeyer, PhD, Barrett H. Childs, MD, Martin H. Dreyling, MD PhD
Journal: Blood
Blood (2015) 126 (23): 3935.
https://doi.org/10.1182/blood.V126.23.3935.3935
Published: 2015
Journal Articles

Phase 2A Study of Copanlisib, a Novel PI3K Inhibitor, in Patients with Indolent Lymphoma

Free
Martin Dreyling, David Cunningham, FMedSci, Krimo Bouabdallah, MD, Sarit Assouline, MD MSc, Eric Van den Neste, Umberto Vitolo, MD, Marius Giurescu, MD PhD, Silvia Mappa, MD, Julia Grunert, Barrett H. Childs, MD, Franck Morschhauser
Journal: Blood
Blood (2014) 124 (21): 1701.
https://doi.org/10.1182/blood.V124.21.1701.1701
Published: 2014
Journal Articles

Preliminary Results Of a Phase II Study Of Single Agent Bay 80-6946, a Novel PI3K Inhibitor, In Patients With Relapsed/Refractory, Indolent Or Aggressive Lymphoma

Free
Martin Dreyling, Franck Morschhauser, MD, PhD, Dominique Bron, MD, PhD, Krimo Bouabdallah, MD, Umberto Vitolo, MD, Kim Linton, Eric Van Den Neste, MD, PhD, Silvia Mappa, MD, Marius Giurescu, MD, PhD, Barrett H. Childs, MD, Pier Luigi Zinzani, MD
Journal: Blood
Blood (2013) 122 (21): 87.
https://doi.org/10.1182/blood.V122.21.87.87
Published: 2013